الفهرس 
Introduction & Aim of the workOnly 14 pages are availabe for public view
 |  | from | 76 |  |  |
| | | from | 76 | | |
Abstract
Profound vein apoplexy (DVT) alludes to the arrangement of at least one blood clumps in one of the body’s enormous veins, most ordinarily in the lower limits. The coagulation can cause halfway or complete blockage of dissemination in the vein, causing torment, expanding, delicacy, and skin staining that feels hot to the touch in certain patients. Anticoagulants are the pillar of treatment for VTE, which comprises of profound vein apoplexy and aspiratory embolism. Treatment of VTE incorporates direct oral anticoagulants (DOACs), starting parenteral anticoagulation followed by a DOAC, or introductory parenteral anticoagulation overlaid with warfarin. The point of this study is to analyze the impact of LMWH for multi week followed by DOACs (rivaroxaban or apixaban) versus DOACs from gauge in the treatment of broad proximal lower limit DVT. The current review was done in the period between May 2021 and January 2022 at the Department of General Surgery of the Faculty of Medicine of the University of Minia. It was performed on 40 subjects after endorsement by the morals panel and composed assent from every understanding. Subjects: subjects tried out the review were assembled as follows: group I: enlisted (20) patients with DVT treated with LMWH for multi week followed by DOACs. Bunch II: included (20) patients with DVT treated with DOACs from standard. Confirmation models: 3. Age north of 18 years and under 80 years. 4Extensive proximal DVT. Prohibition models: 7. Age under 18 years or over 80 years 8. Late cerebral drain 9. Dynamic gastric ulcer 10. Pregnancy 11.Nursing suspension 12.distal DVT All points remembered for the review were oppressed as follows: 1) Care history: considering age, sex, comorbidities, term of the illness, hazard factors, ongoing exchanges, previous DVT and family ancestry.